Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zydus Wellness's earnings before interest and taxes (EBIT) for the
three
months ended in Mar. 2026 was ₹2,160 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹3,286 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Zydus Wellness's annualizedROC % for the quarter that ended in Mar. 2026 was 7.93%.
Zydus Wellness's annualizedROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 88.95%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Zydus Wellness's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 1.56%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zydus Wellness EBIT Related Terms
Zydus Wellness EBIT Historical Data
* Premium members only.
The historical data trend for Zydus Wellness's EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Zydus Wellness's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zydus Wellness EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Zydus Wellness's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Zydus Wellness's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,286 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zydus Wellness (BOM:531335) has a EBIT of ₹3,286 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Zydus Wellness.
Is Zydus Wellness' EBIT too high?
Zydus Wellness' current EBIT is ₹3,286 Mil. Overall, Zydus Wellness has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zydus Wellness' EBIT compare to KHC and GIS?
Zydus Wellness' EBIT of ₹3,286 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Zydus Wellness. Zydus Wellness's current EBIT is ₹3,286 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zydus Wellness stock overvalued right now?
Based on GuruFocus' analysis, Zydus Wellness (BOM:531335) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹638.58, compared to a current price of ₹565.85 — trading 11.4% below its estimated fair value. The current EBIT is ₹3,286 Mil. Zydus Wellness' overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Zydus Wellness (BOM:531335), the current EBIT is ₹3,286 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zydus Wellness (BOM:531335) Overvalued in 2026?
Based on GuruFocus' analysis, Zydus Wellness stock appears to be undervalued.
The current stock price of ₹565.85 is trading 11.4% below its estimated GF Value™ of ₹638.58.
GuruFocus considers Zydus Wellness to be Modestly Undervalued.
Key valuation signals for BOM:531335:
EBIT: ₹3,286 Mil
GF Value™: ₹638.58 vs. price of ₹565.85 (11.4% below fair value)
No single metric tells the full story. See the BOM:531335 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zydus Wellness Ltd is engaged in the production and distribution of health and wellness products. It has several brands, including Everyuth, Sugar-Free, and Nutralite. The company offers specialty skincare products under the brand Everyuth Naturals. Zydus's sugar-free product portfolio, a sugar substitute category, consists of Sugar-Free gold for tabletop usage and Sugar-Free Natura for culinary usage. The firm also offers healthy foods, including Nutralite, a healthy butter substitute. Company brands includes: Complan, Sugar Free, Glucon-D, Everyuth, Nycil, Nutralite, and Others.
85GF Score
Get the complete analysis for BOM:531335
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531335 has been successfully added to your 
